Braidwell’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.9M	Sell	652,121 -99,413	-13%	-$13.2M	2.87%	5
2025 Q4	$107M	Sell	751,534 -128,748	-15%	-$18.7M	3.41%	5
2025 Q3	$124M	Sell	880,282 -280,143	-24%	-$38M	3.67%	6
2025 Q2	$146M	Sell	1,160,425 -31,500	-3%	-$3.61M	4.99%	3
2025 Q1	$132M	Buy	1,191,925 +290,135	+32%	+$36.8M	4.63%	3
2024 Q4	$123M	Sell	901,790 -15,884	-2%	-$1.96M	3.65%	4
2024 Q3	$106M	Buy	917,674 +158,665	+21%	+$21.8M	3%	7
2024 Q2	$104M	Buy	759,009 +28,800	+4%	+$3.95M	3.28%	5
2024 Q1	$101M	Buy	730,209 +15,000	+2%	+$2.05M	3.25%	7
2023 Q4	$94.2M	Sell	715,209 -252,815	-26%	-$29.1M	3.46%	6
2023 Q3	$109M	Buy	968,024 +34,662	+4%	+$3.65M	3.44%	7
2023 Q2	$88M	Buy	933,362 +166,562	+22%	+$16.3M	2.88%	8
2023 Q1	$77.6M	Buy	+766,800	New	+$79.8M	2.56%	10